Actively Recruiting
Meloxicam in Mohs Micrographic Surgery
Led by University of Oklahoma · Updated on 2025-12-15
300
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to explore alternative methods of postoperative pain control in Mohs micrographic surgery. The main aims are: * To provide more information to the Mohs surgery community regarding postoperative pain control. * Reducing pain improves the overall comfort and well-being of patients, leading to a better post-operative experience. * To provide patients with an alternative and potentially superior NSAID for pain control (compared to standard-of-care ibuprofen). Researchers will compare 1) a single of dose Meloxicam 7.5 mg, followed by acetaminophen 500 mg; 2) a single dose of Meloxicam 15 mg, followed by acetaminophen 500 mg; 3) a single dose of acetaminophen 500 mg, followed by alternating ibuprofen 200 mg and acetaminophen 500 mg to see which better moderate pain control and patient satisfaction. Participants will be asked to complete pain and patient satisfaction surveys.
CONDITIONS
Official Title
Meloxicam in Mohs Micrographic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults undergoing Mohs micrographic surgery at the University of Oklahoma
- Willing and able to provide consent to participate in the study
You will not qualify if you...
- Women who are pregnant, suspect they are pregnant, or plan to become pregnant during the study
- Chronic liver disease including hepatitis, cirrhosis, NASH, NAFLD, alcoholic liver disease, hemochromatosis, or Wilson's disease
- Chronic kidney disease stage III or higher
- Aspirin-sensitive asthma
- History of regular chronic NSAID use
- Patients at risk for drug interactions
- History of gastrointestinal bleeding or peptic ulcers
- Non-English speakers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104
Actively Recruiting
Research Team
C
Chase Pitchford, MD
CONTACT
L
Landon Hendrickson, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here